Retail drug sales in year to March 2008

15 June 2008

Retail pharmacy drug sales in 13 major markets during the 12 months to February 2008 have reached $424.9 billion, reports IMS Health's Retail Drug Monitor. This is a rise of 7.5% compared with $395.4 billion for the year ended March 2007, continuing a slight slowdown from the start of the year (Marketletter April 21). Since the last report, Canada has caught up with Italy, the latter being the only market to experience a contraction. The fastest-growing region remains Australia and New Zealand, with a combined market of $7.5 billion, up 11%.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >






Company Spotlight